Skip to main content
EIKN
NASDAQ Life Sciences

Eikon Posts $86.1M Q3 Loss, Cash Runway Extended Into Q1 2028

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$6.66
Mkt Cap
$361.281M
52W Low
$5.01
52W High
$17.4
52W Position info
33% above low
Off High info
62% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

EIKN sits 33% above its 52-week low of $5.01.

Summary

Eikon reported a Q3 2026 net loss of $86.1 million, or $1.59 a share, wider than the $71.1 million loss a year earlier, as R&D spending rose 21% to $71.8 million. It ended September with $461.7 million in cash and marketable securities and now expects that to fund operations into the first quarter of 2028, covering the key 2027 readouts. The clinical update largely recaps the ESMO data already disclosed in the October 23 and October 26 8-Ks, including the 63.1% ORR for EIK1001 in the pooled NSCLC population. The one genuinely new regulatory item is the October 14 IND filing for EIK1006 in metastatic prostate cancer. Next hard catalysts are the TeLuRide-006 interim analysis in the first half of 2027 and TeLuRide-008 dose selection in the second half of 2027.

At the time of this announcement, EIKN was trading at $6.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $361.3M. The 52-week trading range was $5.01 to $17.40. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

EIKN - Latest Insights

EIKN
Oct 26, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.90
Real-time Price: $6.10 info
Change: -$0.800 (-12%) info
Market Cap: $327.157M info
EIKN
Oct 23, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.24
Real-time Price: $6.10 info
Change: -$2.14 (-26%) info
Market Cap: $327.157M info
EIKN
Aug 13, 2026, 8:44 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.52
Real-time Price: $6.10 info
Change: -$4.42 (-42%) info
Market Cap: $327.157M info
EIKN
Aug 13, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $10.18
Real-time Price: $6.10 info
Change: -$4.08 (-40%) info
Market Cap: $327.157M info
EIKN
Aug 13, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.18
Real-time Price: $6.10 info
Change: -$4.08 (-40%) info
Market Cap: $327.157M info